MGZ reports consulting fees from Ikena Oncology, the Takeda Pharmaceutical Company, GlaxoSmithKline, Aldeyra Therapeutics, and Novocure; honoraria for Continuing Medical Education content from Physicians’ Education Resource, Medscape, Research to Practice, Medical Learning Institute, and OncLive; research funding to Memorial Sloan Kettering Cancer Center from PreCog, GlaxoSmithKline, Epizyme, Polaris, Sellas Life Sciences, Bristol Myers Squibb, the Takeda Pharmaceutical Company, Curis, and Atara; and is chair of the board of directors of the Mesothelioma Applied Research Foundation (uncompensated). MO reports consulting fees Novartis and Jazz Pharmaceuticals; honoraria for CME content for OncLive, Targeted Oncology, and ASTRO; and is part of the scientific advisory board for the Mesothelioma Applied Research Foundation (uncompensated).